Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Insulin sensitizers for improving the endocrine and metabolic profile in overweight women with PCOS
By reactivating telomerase, Epitalon aims to extend the replicative capacity of somatic cells, delaying the onset of telomere-driven cellular aging
MedicalDaily Evidence Check Study type: Phase 3 randomized controlled trial (ATTAIN program) Participants: Adults with obesity or overweight with at least one weight-related comorbidity Approval date: April 1, 2026 What it found: Average weight loss of approximately 12.4% (about 27 lbs) at highest dose over 72 weeks What it did not prove: That it matches injectable GLP-1 efficacy
clinicians prior to publication
Evidence of structural protein damage and membrane lipid remodeling in red blood cells from COVID-19 patients
US$ 27.13
US$ 28.27
US$ 23.46
US$ 26.69
US$ 26.99
